SAB BIOTHERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.25 USD | +5.98% |
|
-0.93% | -38.18% |
| Apr. 16 | SAB Biotherapeutics, Inc. Provides SAB-142 Trial Update | CI |
| Apr. 02 | HC Wainwright Adjusts Price Target on SAB Biotherapeutics to $6 From $10, Maintains Buy Rating | MT |
Chart calendar SAB Biotherapeutics, Inc.
78acd1440a3bf24aa.UCCV85f0N73CBCLoCvzYGokpZjnPE4qKFZUXy1WQvfM.Onb4kKHMQd-aTEShXb2IQMRPAFeXXO7IX8Vt_GX9-pE2FsSj4pdV14ZSTQ~42ae1428df67f6ebc7b0dbe3153e57f9
Upcoming events on SAB Biotherapeutics, Inc.
Past events on SAB Biotherapeutics, Inc.
| 2024-04-11 01:30 pm | Needham Healthcare Conference |
| 2024-02-26 03:15 pm | BIO CEO & Investor Conference |
| 2024-02-13 01:20 pm | Oppenheimer Healthcare Life Sciences Conference |
| 2024-01-02 10:00 am | Extraordinary Shareholders Meeting |
| 2023-11-29 01:30 pm | Piper Sandler Healthcare Conference |
| 2023-11-21 | Extraordinary Shareholders Meeting |
| 2023-11-14 07:15 am | Q3 2023 Earnings Release |
| 2023-09-12 12:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-21 08:30 am | Q2 2023 Earnings Release |
| 2023-06-29 10:00 am | Annual General Meeting |
| 2023-06-22 06:30 pm | Federation of Clinical Immunology Societies Meeting |
| 2023-06-14 02:30 pm | R&D Day |
| 2023-06-07 03:45 pm | BIO International Convention |
| 2023-05-14 | Q1 2023 Earnings Release |
| 2023-05-10 11:30 am | Sidoti Micro-Cap Virtual Conference |
| 2023-05-07 | Investor Meeting |
| 2023-05-03 | ISIRV-AVG Conference |
| 2023-03-31 05:00 pm | Q4 2022 Earnings Release |
| 2023-02-06 11:15 am | BIO CEO and Investor Conference |
| 2023-01-10 05:30 pm | Biotech Showcase meeting |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 55,2 | 60,9 67,9 -10.34% | 23,9 28,2 -15.33% | 2,24 1,12 100.27% | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -13,4 -8,16 -64.11% | -28,9 -26,2 -10.5% | -38,1 -25,9 -47.2% | -47,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -17,1 -6,77 -153.39% | -18,7 -15,8 -18.26% | -42,2 -26,1 -61.86% | -45,2 |
|
Net income Million USD | Released Forecast Spread | 20,1 | -17,1 -8,04 -113.13% | -18,7 -15,9 -18.05% | -42,2 -26,1 -61.86% | -45,2 |
|
EPS USD | Released Forecast Spread | 0,00 | -6,30 -2,13 -195.31% | -4,30 -3,37 -27.72% | -7,64 -4,22 -81.26% | -4,31 |
| Announcement Date | 17/08/21 | 29/03/22 | 14/04/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 11,1 15,0 -26.29% | 11,8 11,5 2.81% | 6,35 10,8 -41.2% | 3,59 6,86 -47.63% | 2,16 6,50 -66.77% | 0,58 2,53 -76.99% | 0,09 0,41 -78.97% | 1,27 0,01 9407.58% | 0,31 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -7,34 -5,17 -42.19% | -6,71 -5,62 -19.4% | -6,54 -5,78 -13.28% | -7,81 -7,87 0.84% | -7,86 -5,12 -53.62% | -7,40 -5,01 -47.85% | -6,48 -7,26 10.81% | -5,32 -6,80 21.76% | -18,9 -6,67 -183.18% | -9,68 | -11,1 | -12,2 | -14,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,6 -7,93 -45.76% | 1,08 -7,49 114.39% | -4,87 -5,67 14.19% | -7,08 -7,36 3.81% | -7,85 -4,96 -58.17% | -7,35 -5,06 -45.33% | -6,88 -7,31 5.9% | -5,10 -6,86 25.64% | -22,9 -6,73 -239.57% | -9,07 | -10,6 | -11,8 | -13,8 |
|
Net income Million USD | Released Forecast Spread | -11,6 -6,47 -78.61% | 0,99 -6,14 116.05% | -4,78 -5,72 16.55% | -7,08 -7,41 4.45% | -7,87 -5,01 -57.1% | -7,35 -5,11 -44.05% | -6,88 -7,36 6.54% | -5,10 -6,86 25.64% | -22,9 -6,73 -239.57% | -9,07 | -10,6 | -11,8 | -13,8 |
|
EPS USD | Released Forecast Spread | -4,70 -1,45 -224.14% | 0,20 -1,55 112.9% | -1,10 -1,35 18.52% | -1,60 -1,43 -11.63% | -1,80 -0,87 -107.69% | -1,50 -1,17 -28.57% | -1,40 -1,40 0% | -1,00 -1,17 14.29% | -7,26 -0,62 -1070.97% | -0,96 | -1,03 | -1,11 | -1,21 |
| Announcement Date | 29/03/22 | 12/05/22 | 10/08/22 | 14/11/22 | 14/04/23 | 15/05/23 | 21/08/23 | 13/11/23 | 29/03/24 | - | - | - | - |
More events
Past sector events for SAB Biotherapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SABS Stock
- Calendar SAB Biotherapeutics, Inc.
